Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yakir Segev

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Harefuah|February 3, 2006
[Nutrition and pharmacological treatment for prevention of prostate cancer]Yakir Segev, Ofer Nativ
Harefuah|November 6, 2025
[Like an Anchor in a Stormy Sea: A Multi-Disciplinary Integrative and Palliative Care Intervention for a Patient with Ovarian Cancer]Galit Galil, Mattan Ophir, Yakir Segev
Familial Cancer|May 20, 2014
Genetics of endometrial cancerAyelet Shai, Yakir Segev, Steven A Narod
Obstetrical & Gynecological Survey|April 21, 2010
Is there a place for adjuvant therapy in IVF?Yakir Segev, Howard Carp, Ron Auslender, et al.
Harefuah|November 25, 2014
[Advanced ovarian cancer: primary debulking (PDS) or neoadjuvant chemotherapy (NACT) - still a debate]Yakir Segev, Ofer Gemer, Ron Auslender, et al.
JSLS : Journal of the Society of Laparoendoscopic Surgeons|February 22, 2011
Laparoscopic removal of an intrauterine device following colon perforationArie Bitterman, Oleg Lefel, Yakir Segev, et al.
Harefuah|August 31, 2017
[LOW GRADE OVARIAN CANCER]Yakir Segev, Anis Kaldawy, Ron Auslender, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Ovarian carcinosarcomas associated with prolonged use of tamoxifen: case reportsOfer Lavie, Teri Longacre, Yakir Segev, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 2, 2023
Attitude of BRCA1/2 mutation carriers towards surgical risk reduction for breast, ovarian and uterine cancer: still much to be doneChen Nahshon, Yakir Segev, Meirav Schmidt, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 13, 2022
Attitudes of Israeli gynecologists towards risk reduction salpingo-oophorectomy at hysterectomy for benign conditions and the use of hormonal therapyWissam Assaf, Marah Andraous, Ofer Lavie, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Harefuah|February 3, 2006
[Nutrition and pharmacological treatment for prevention of prostate cancer]Yakir Segev, Ofer Nativ
Harefuah|November 6, 2025
[Like an Anchor in a Stormy Sea: A Multi-Disciplinary Integrative and Palliative Care Intervention for a Patient with Ovarian Cancer]Galit Galil, Mattan Ophir, Yakir Segev
Familial Cancer|May 20, 2014
Genetics of endometrial cancerAyelet Shai, Yakir Segev, Steven A Narod
Obstetrical & Gynecological Survey|April 21, 2010
Is there a place for adjuvant therapy in IVF?Yakir Segev, Howard Carp, Ron Auslender, et al.
Harefuah|November 25, 2014
[Advanced ovarian cancer: primary debulking (PDS) or neoadjuvant chemotherapy (NACT) - still a debate]Yakir Segev, Ofer Gemer, Ron Auslender, et al.
JSLS : Journal of the Society of Laparoendoscopic Surgeons|February 22, 2011
Laparoscopic removal of an intrauterine device following colon perforationArie Bitterman, Oleg Lefel, Yakir Segev, et al.
Harefuah|August 31, 2017
[LOW GRADE OVARIAN CANCER]Yakir Segev, Anis Kaldawy, Ron Auslender, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Ovarian carcinosarcomas associated with prolonged use of tamoxifen: case reportsOfer Lavie, Teri Longacre, Yakir Segev, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 2, 2023
Attitude of BRCA1/2 mutation carriers towards surgical risk reduction for breast, ovarian and uterine cancer: still much to be doneChen Nahshon, Yakir Segev, Meirav Schmidt, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 13, 2022
Attitudes of Israeli gynecologists towards risk reduction salpingo-oophorectomy at hysterectomy for benign conditions and the use of hormonal therapyWissam Assaf, Marah Andraous, Ofer Lavie, et al.
Pageof 9